• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·TNON
Share

Tenon Medical, Inc. Stocks

$ 0.62Last Updated 15.06.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 4.56M

$ 0.62
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tenon Medical, Inc. is a medical device firm dedicated to developing advanced surgical implant solutions. These systems are designed to enhance sacroiliac joint (SIJ) fixation and fusion operations, ultimately leading to better patient outcomes. The company markets The CATAMARAN SIJ Fusion System, which includes both specialized instruments and implants, specifically engineered for the preparation and secure fusion of the SI-Joint. This product is distributed throughout the United States and Puerto Rico. Founded in 2012, Tenon Medical's operations are headquartered in Los Gatos, California.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.06.2026 22:30

OpenAI's revenue isn't keeping up with its expenses: ahead of its IPO, they totaled $34 billion — FT

16.06.2026 22:02

"Not a 'meme stock'": Why does an analyst believe Nebius shares are overvalued by more than 50%?

16.06.2026 21:29

Cathie Wood's funds bought 3 million shares of SpaceX. This is one of ARK's biggest moves in years.

16.06.2026 20:51

Britain is investigating reports of gunfire from a Russian warship in the English Channel

16.06.2026 20:38

Recently pivoted to quantum computing, QTREX soars 70% on production milestone

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026